INNT
TOTAL INVALIDATION PROCESSED BY THE IB
04/07/2025
Voltar para busca
Dado oficial do USPTO
EVER IMMUNE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
05/07/2025
Tipo de marca
Mista
Classes Nice
5, 9, 10, 42, 44
Data de depósito
04/08/2016
Data de registro
02/01/2018
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/07/2024
Última transação
05/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
FR
Examinador
THOMAS, JULIE
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "ever Immune" in black with four incomplete blue and black ovals to the left of the wording "ever". A blue filled black circle dots the letter "I". The color white represents background and is not a feature of the mark.
Titulares e representantes
Titulares
EVERIMMUNE
G. T. (pessoa física)
Representantes
Bruce S. Londa Norris McLaughlin P.A.
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
pharmaceutical productspharmaceutical preparationsmedicines and vaccines for treatment and prevention of cancer
Classe 9
Computer programs for aiding in the detectionrecognitionevaluationdiagnosis and characterization of cancerfor aiding for the treatment and prevention of cancerfor searching for similar cases in databases or archiving systemsfor generating analytical or diagnostic reports; software for aiding in the detectionrecognitionevaluationdiagnosis and characterization of cancerfor aiding for the treatment and prevention of cancerfor searching for similar cases in databases or archiving systemsfor generating analytical or diagnostic reports; recorded computer programs regardless of the medium for aiding in the detectionrecognitionevaluationdiagnosis and characterization of cancerfor aiding for the treatment and prevention of cancerfor searching for similar cases in databases or archiving systemsfor generating analytical or diagnostic reports; pre-recorded magneticelectronicopticalmagneto-optical data mediamemory cardsCD-ROMsdigital videodisks featuring information on cancer; pre-recorded optical disks featuring information on cancer; pre-recorded magneto-optical disks featuring information on cancer; pre-recorded magnetic tapes featuring information on cancer; downloadable or non-downloadable software for aiding in the detectionrecognitionevaluationdiagnosis and characterization of cancerfor aiding for the treatment and prevention of cancerfor searching for similar cases in databases or archiving systemsfor generating analytical or diagnostic reports; computer programs and software used for the acquisitionvisualizationprocessingexploitationannotationstoragesearchingdissemination and printing of all types of medical dataespecially of images obtained by a radiographic means by X-rayscannerpetscanultrasonographymagnetic resonancetomography for the purpose of cancer screeningdiagnosis or treatmentin the medicalsurgical and health field and in cancer research; apparatus for recordingtransmission and reproduction of sound or images; data processing equipment for processing informationcomputers
Classe 10
Surgicalmedicaldental and veterinary apparatus and instruments namelyx-ray apparatusscannerpositron emission tomography (PET) scannersmagnetic resonance imaging scannerultrasound scannerradiotherapy treatment apparatusartificial limbseyes and teeth; orthopedic articles namelyorthopedic implantsorthopedic bandages and splintsorthopedic braces; suture material
Classe 42
Scientific research servicesnamely cancer researchmedical research servicesresearch and development of new medical productsresearch in the fields of bacteriologybiologychemistry; scientific information services in the field of the fight against cancerclinical researchresearch and biology laboratories; research for new treatments and pharmaceutical productsvaccinesmedicines against cancer
Classe 44
Medical services; hospital services; medical analyses namelymedical testing for diagnostic or treatment purposes; medical expertise services namelymedical diagnostic testingmonitoringreporting and performing a diagnosis of cancer; health services namelytreatment of cancer; medical and surgical services; medical imagingradiotherapybrachytherapy and medical dosimetry services for treating cancer; medical diagnosis services namelyanalysis and interpretation of images generated by x-ray apparatusscannerpositron emission tomography (PET) scannermagnetic resonance imaging scannerultrasound scanner; medical information services in the field of the fight against cancerinformation on cancer treatment
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
14/06/2025
INPC
INVALIDATION PROCESSED
14/06/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
19/03/2025
C71T
CANCELLED SECTION 71
19/07/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/04/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/01/2023
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
07/10/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
04/07/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
22/05/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/02/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/01/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
19/05/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/04/2018
FIMP
FINAL DISPOSITION PROCESSED
12/04/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/04/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
02/01/2018
GPNX
NOTIFICATION PROCESSED BY IB
21/10/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/10/2017
PUBO
PUBLISHED FOR OPPOSITION
17/10/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/10/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/10/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/09/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/09/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
01/09/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/09/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
01/09/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/09/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/08/2017
GNRT
NON-FINAL ACTION E-MAILED
22/08/2017
CNRT
NON-FINAL ACTION WRITTEN
22/08/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
23/07/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/07/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/07/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/07/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/07/2017
RFNT
REFUSAL PROCESSED BY IB
03/02/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/01/2017
RFRR
REFUSAL PROCESSED BY MPU
13/01/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
31/12/2016
CNRT
NON-FINAL ACTION WRITTEN
30/12/2016
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
29/12/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
24/12/2016
MAFR
APPLICATION FILING RECEIPT MAILED
24/12/2016
CNRT
NON-FINAL ACTION WRITTEN
23/12/2016
DOCK
ASSIGNED TO EXAMINER
20/12/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/12/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
15/12/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EVER IMMUNE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.